Could 'fusion proteins' reduce errors in a promising gene-editing tool?
08 May, 2026Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies. Now, Australian scientists believe they've made it safer.
Ecopha Biotech announces strategic cross-border model
01 May, 2026To commercialise its ecopha.bio technology for a Pongamia-based bioeconomy, Australian company Ecopha Biotech has announced an Australia–India strategy.
$96m RNA Research and Manufacturing Facility opens in NSW
30 April, 2026The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University Innovation Precinct will produce new and existing RNA therapeutics.
Cartherics and Catalent announce enhanced partnership
23 April, 2026To support immune cell therapy products for the treatment of cancer and endometriosis, Australian biotech Cartherics has announced an enhanced partnership with Catalent.
CTA granted for CAR-T cell therapy for multiple myeloma
02 April, 2026The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell immunotherapy for multiple myeloma.
How Cell-Free Synthesis is Revolutionising Biotechnology
01 April, 2026As biotechnology evolves, innovations in DNA manufacturing may prove as essential as the discovery of DNA itself, enabling faster, safer, and more flexible research and development.
Whisper-quiet precision for modern analytical devices
01 April, 2026Bürkert's Whisper Valves are compact electromagnetic micro-valves designed for highly precise dosing and fluid control.
Sensor's cell-like structure said to overcome key blood-testing barrier
25 March, 2026Drawing inspiration from nature, Australian researchers have developed a sensor they believe overcomes one of the biggest barriers in blood testing.
Aussie biotech to manufacture mRNA paediatric brain cancer vaccines
05 March, 2026A Queensland-based biotechnology company will manufacture personalised mRNA paediatric brain cancer vaccines for a clinical trial commencing this month.
Could this biosensor bypass labs with onsite PFAS detection?
17 February, 2026La Trobe University has developed a portable biosensor that may allow rapid, onsite detection of toxic 'forever chemicals' in water.
Noxopharm says paper reveals science behind its immune system platform
13 February, 2026Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology paper reveals the science behind its immune system platform, Sofra.
Neurosensing/neurostimulation implants session to be held on Monday
12 February, 2026On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics discussing their lived experience.
Archer completes potassium sensing alpha prototype
02 February, 2026Quantum technology company Archer Materials Limited has developed an early Biochip prototype designed to detect chronic kidney disease.
Mini lung organoids could help test new treatments
04 December, 2025Scientists have developed a simple method for automated the manufacturing of lung organoids — clusters of cells containing the same cell types as full-sized organs.
Heart implant brings hope to refractory angina patients
02 December, 2025The coronary sinus reducer is understood to redistribute blood flow within the wall of the heart, improving oxygen supply in the parts of the heart muscle where it is needed most.
